|
The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. ---------- Main Market small-cap winners ---------- DeFi Development Corp UK PLC, up 291% at 45 pence, proposes name change and replaces CEO Macau Property Opportunities Fund Ltd, up 14% at 6.15p RC365 Holding PLC, up 14% at 2.05p Cindrigo Holdings Ltd, up 11% at 5.00p Zenith Energy Ltd, up 7.8% at 4.85p ---------- Main Market small-cap losers ---------- Nuformix PLC, down 10% at 0.18p Gabelli Merchant Partners PLC, down 9.9% at $7.75 Smarter Web Co PLC, down 6.3% at 25.30p Bluebird Mining Ventures Ltd, down 5.0% at 0.05p Satsuma Technology PLC, down 4.8% at 0.20p ---------- AIM winners ---------- tinyBuild Inc, up 14% at 10.25p Light Science Technologies Holdings PLC, up 14% at 1.65p Oxford BioDynamics PLC, up 11% at 0.15p Europa Oil & Gas Holdings PLC, up 10% at 1.70p Futura Medical PLC, up 9.4% at 0.55p, terminates commercial partnership with Haleon, replaces with Market Performance Group ---------- AIM losers ---------- River Global PLC, down 63% at 2.25p Mothercare PLC, down 14% at 0.84p Nativo Resources PLC, down 13% at 0.23p, says La Patona gold plant ready for construction Fiinu PLC, down 13% at 5.13p, pretax loss widens Marechale Capital PLC, down 11% at 6.25p ---------- Small-cap and AIM movers in focus: ---------- DeFi Development Corp UK PLC, up 291% at 45 pence, 12-month range 10.00p-95.00p. The provider of an AI platform that allows businesses to automate tasks says it plans to change its name back to Cykel AI, reversing a change that took place in January. ‘The board believes that the change of name better reflects the company’s strategic repositioning and renewed focus on artificial intelligence,’ it says. Non-Executive Chair Hadley Stern, Chief Executive Officer Michael Chan and Chief Financial Officer Nathalie Maggi will step down from the company on Tuesday. The firm appoints Gerald Tritt as CEO. He currently serves as CEO of Jolt Health and Clara Technologies, two listed health and wellness companies. The company agrees to extend the deadline on £2.8 million of warrants to June 29, 2028. The previous deadline ended last Monday. ‘The board is confident that the extension will allow the company to progress its development in an orderly manner and is committed to updating shareholders as and when there are material developments,’ it adds. ---------- Futura Medical PLC, up 9.4% at 0.55p, 12-month range 0.50p-15.00p. The Guildford, Surrey-based developer of sexual health products says it has terminated its commercial partnership with Haleon PLC for Eroxon in the US market, and replaced the FTSE 100 firm with Market Performance Group. Futura Medical says US Eroxon sales progress has been slower than expected after launching in October 2024. ‘Alongside this, whilst the market opportunity is clear to both parties, its strategic importance to Haleon has lessened. Futura has therefore reached an agreement with Haleon to terminate its partnership,’ it says. Futura and Haleon have agreed an early termination fee of $1.9 million. The distribution agreement with MPG will start from September 2026. Chief Executive Officer Alex Duggan says: ‘The scale of the market opportunity remains strong, and we believe success in the US is both achievable and significant with the right targeted marketing and distribution strategy.’ ---------- Nativo Resources PLC, down 13% at 0.23p, 12-month range 0.20p-0.90p. The gold miner and processor in Peru says it has completed engineering design, equipment schedule, procurement planning and detailed project costings for the La Patona gold ore processing plant. It says the site is now ‘effectively construction-ready’, subject to completion of project financing. ‘We continue to engage with a number of potential financing partners and remain encouraged by the level of interest in the project,’ says Chief Executive Stephen Birrell. ---------- Fiinu PLC, down 13% at 5.13p, 12-month range 4.50p-21.00p. Reports a wider loss for 2025. The Weybridge, Surrey financial technology provider says its pretax loss widened to £10.4 million in 2025 from £700,068 in 2024. The company reports revenue of £662,666 for the year, up from none in 2024. It faces an exceptional items charge of £8.6 million, compared to none a year earlier, as it recognised a £7.3 million non-cash goodwill impairment charge relating to the Everfex acquisition. Chief Executive Officer Marko Sjoblom says: ‘While disappointing, this accounting adjustment does not affect the group’s cash resources, operational performance or strategic rationale for the acquisition. Everfex continues to provide revenue generation, a foothold in Central Europe and opportunities to support the group’s wider growth ambitions.’ ---------- Xtract Resources PLC, down 6.0% at 1.18p, 12-month range 0.50p-1.50p. The Australia and Zambia-focused miner says its pretax loss widens to £1.9 million in 2025 from a loss of £419,000 a year earlier. Operating and administrative expenses climb to £2.2 million from £1.4 million. Executive Chair Colin Bird says: ‘We believe that tariffs, supply manipulation and geo-political uncertainties will not affect an overwhelming demand for copper, but may affect the supply side in terms of large company commitment to certain regions of the world and certain regions being not receptive to new investment sources.’ ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
